Sino Biological, provider of biological research reagents and related technical contract research services, has expanded to a new location in Houston, Texas.
The company has headquarters in Beijing, China and subsidiaries in Suzhou (China), Taizhou (China), Frankfurt (Germany), and Wayne (Pennsylvania, US). The new location in Houston allows for direct access via a close proximity to local Texas- and central-US-based pharmaceutical and biotechnology companies as well as the Texas Medical Center. The new site opened on January 3, 2022.
“Texas is at the forefront of drug discovery and diagnostic development and leads the world in breakthrough research discoveries. Our new strategic location in Houston will provide invaluable access to key players and clients in the pharmaceutical, biotechnology and basic research sectors”, said Rob Burgess, Chief Business Officer of Sino Biological.
